SGB for COVID-induced Parosmia

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

October 25, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
COVID-19-Induced Parosmia
Interventions
DRUG

Stellate Ganglion Block

The stellate ganglion will be identified using ultrasound guidance, and after negative aspiration, 6-8 mL of 1% mepivacaine will be injected near the stellate ganglion.

DRUG

Placebo Sham Injection

The stellate ganglion will be identified using ultrasound guidance, and after negative aspiration, 6-8 mL of 0.9% saline will be injected near the stellate ganglion.

Trial Locations (1)

63122

Nyssa Fox Farrell, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT06253806 - SGB for COVID-induced Parosmia | Biotech Hunter | Biotech Hunter